<DOC>
	<DOCNO>NCT01390766</DOCNO>
	<brief_summary>This post-marketing surveillance ( PMS ) study design investigate efficacy safety azathioprine tablet Japanese subject liver transplantation perform .</brief_summary>
	<brief_title>Drug Use Investigation IMURAN ( Azathioprine ) Tablet ( Hepatic Transplantation )</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Subjects undergo liver transplantation azathioprine tablet administer As PMS study , exclusion criterion contraindication follow . Subjects hypersensitivity ingredient azathioprine tablet Subjects pregnant might pregnant Subjects whose white count lower 3000/cubic millimeter</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Antirejection</keyword>
</DOC>